ATHERONOVA INC. SECOND AMENDED AND RESTATEDConvertible Security Agreement • June 20th, 2012 • AtheroNova Inc. • Pharmaceutical preparations • California
Contract Type FiledJune 20th, 2012 Company Industry JurisdictionTHIS SECOND AMENDED AND RESTATED 2.5% SENIOR SECURED CONVERTIBLE NOTE (this “Note”) is one of a series of duly authorized and validly issued Second Amended and Restated 2.5% Senior Secured Convertible Notes (the “Notes”) of AtheroNova Inc., a Delaware corporation (the “Company”), having its principal place of business at 2301 Dupont Drive, Suite 525, Irvine, CA 92612.
ADAMIS PHARMACEUTICALS CORPORATION 10% SENIOR CONVERTIBLE NOTEConvertible Security Agreement • June 15th, 2012 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • New York
Contract Type FiledJune 15th, 2012 Company Industry JurisdictionTHIS NOTE is a duly authorized and validly issued 10% Senior Convertible Note of ADAMIS PHARMACEUTICALS CORPORATION, a Delaware corporation (the “Company”), having its principal place of business at 11455 El Camino Real, Suite 310, San Diego, CA 92130 (this “Note”).
ADAMIS PHARMACEUTICALS CORPORATION 10% SENIOR SECURED CONVERTIBLE NOTEConvertible Security Agreement • January 15th, 2010 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • New York
Contract Type FiledJanuary 15th, 2010 Company Industry JurisdictionTHIS NOTE is one of a series of duly authorized and validly issued 10% Senior Secured Convertible Notes of ADAMIS PHARMACEUTICALS CORPORATION, a Delaware corporation (the “Company”), having its principal place of business at 2658 Del Mar Heights Rd., #555, Del Mar, CA 92014, designated as its 10% Senior Secured Convertible Notes (this Note, the “Note” and, collectively with the other Notes of such series, the “Notes”).